|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 62.38 EUR | -1.42% |
|
-4.29% | -18.73% |
| 05/05 | Weight-loss drugs fuel protein-rich whey craving | RE |
| 05/05 | FOCUS-Weight-loss drugs fuel protein-rich whey craving | RE |
Company Valuation: Danone
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 35,530 | 30,830 | 37,646 | 41,915 | 49,156 | 40,510 | - | - |
| Change | - | -13.23% | 22.11% | 11.34% | 17.28% | -17.59% | - | - |
| Enterprise Value (EV) 1 | 46,030 | 40,937 | 47,867 | 50,516 | 57,587 | 48,284 | 47,349 | 46,581 |
| Change | - | -11.06% | 16.93% | 5.53% | 14% | -16.15% | -1.94% | -1.62% |
| P/E ratio | 18.6x | 33.3x | 45.1x | 20.8x | 27.2x | 16.8x | 15.5x | 14.4x |
| PBR | 2.02x | 1.76x | 2.33x | 2.59x | 2.93x | 2.24x | 2.12x | 1.97x |
| PEG | - | -0.7x | -3.7x | 0x | -2.75x | 0.5x | 1.89x | 1.92x |
| Capitalization / Revenue | 1.46x | 1.11x | 1.36x | 1.53x | 1.8x | 1.44x | 1.39x | 1.34x |
| EV / Revenue | 1.9x | 1.48x | 1.73x | 1.85x | 2.11x | 1.72x | 1.62x | 1.54x |
| EV / EBITDA | 10x | 7.81x | 9.4x | 10.7x | 11.5x | 9.72x | 9.06x | 8.44x |
| EV / EBIT | 13.8x | 12.1x | 13.8x | 14.2x | 15.7x | 12.6x | 11.7x | 10.9x |
| EV / FCF | 18.9x | 19.6x | 18.2x | 16.8x | 20.6x | 17.6x | 17x | 15.5x |
| FCF Yield | 5.28% | 5.11% | 5.5% | 5.94% | 4.86% | 5.69% | 5.87% | 6.44% |
| Dividend per Share 2 | 1.94 | 2 | 2.1 | 2.15 | 2.25 | 2.339 | 2.492 | 2.653 |
| Rate of return | 3.55% | 4.06% | 3.58% | 3.3% | 2.93% | 3.7% | 3.94% | 4.19% |
| EPS 2 | 2.94 | 1.48 | 1.3 | 3.13 | 2.82 | 3.77 | 4.079 | 4.385 |
| Distribution rate | 66% | 135% | 162% | 68.7% | 79.8% | 62% | 61.1% | 60.5% |
| Net sales 1 | 24,281 | 27,661 | 27,619 | 27,376 | 27,283 | 28,055 | 29,186 | 30,313 |
| EBITDA 1 | 4,602 | 5,240 | 5,092 | 4,726 | 5,020 | 4,966 | 5,228 | 5,517 |
| EBIT 1 | 3,337 | 3,377 | 3,481 | 3,558 | 3,665 | 3,824 | 4,062 | 4,290 |
| Net income 1 | 1,924 | 959 | 881 | 2,021 | 1,825 | 2,389 | 2,572 | 2,774 |
| Net Debt 1 | 10,500 | 10,107 | 10,221 | 8,601 | 8,431 | 7,774 | 6,839 | 6,071 |
| Reference price 2 | 54.59 | 49.23 | 58.68 | 65.12 | 76.78 | 63.28 | 63.28 | 63.28 |
| Nbr of stocks (in thousands) | 6,50,849 | 6,26,246 | 6,41,543 | 6,43,653 | 6,40,218 | 6,40,173 | - | - |
| Announcement Date | 23/02/22 | 22/02/23 | 22/02/24 | 26/02/25 | 20/02/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 16.78x | 1.72x | 9.72x | 3.7% | 4.77TCr | ||
| 19.27x | 2.82x | 13.84x | 4.05% | 26TCr | ||
| 21.72x | 2.48x | 14.54x | 3.37% | 7.87TCr | ||
| 23.38x | 3.44x | 13.98x | 3.08% | 3.79TCr | ||
| 17.05x | 0.53x | 10.16x | 2.67% | 3.74TCr | ||
| 86.26x | 12.54x | 56.01x | 0.95% | 3.02TCr | ||
| 37.01x | 3.22x | 17.93x | 0.96% | 3.03TCr | ||
| 11.26x | 1.86x | 9.18x | 6.78% | 2.8TCr | ||
| 14.22x | 0.4x | 9.27x | 2.31% | 2.4TCr | ||
| 35.42x | 0.71x | 18.03x | 0.71% | 2.26TCr | ||
| Average | 28.24x | 2.97x | 17.26x | 2.86% | 5.93TCr | |
| Weighted average by Cap. | 23.87x | 2.87x | 15.49x | 3.4% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- BN Stock
- Valuation Danone
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















